- Stryker acquired Inari Medical in February 2025.
- On July 30, 2026, Stryker reported Q2 results and disclosed supply disruptions in Peripheral Vascular, saying the issue was addressed and backorder would be manageable by end of Q3.
Law firm Hagens Berman is investigating whether Stryker misled investors about a manufacturing issue at its Inari Medical unit. The stock fell 8.8% on Sept. 8 after the CFO said the problem persists despite earlier assurances it was resolved.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.